MARKET

AXSM

AXSM

Axsome Therapeut
NASDAQ
112.16
-4.33
-3.72%
After Hours: 112.10 -0.06 -0.05% 17:30 05/06 EDT
OPEN
115.76
PREV CLOSE
116.49
HIGH
117.37
LOW
110.61
VOLUME
716.11K
TURNOVER
--
52 WEEK HIGH
139.13
52 WEEK LOW
64.11
MARKET CAP
5.52B
P/E (TTM)
-19.4432
1D
5D
1M
3M
1Y
5Y
1D
Axsome Therapeutics Q1: Marketing-Driven Growth Masks Profitability Concerns
Seeking Alpha · 5h ago
AXSM Q1 Loss Narrower Than Expected, Auvelity Drives Revenues Y/Y
NASDAQ · 8h ago
Axsome Therapeutics Is Maintained at Overweight by Wells Fargo
Dow Jones · 8h ago
Wells Fargo Maintains Overweight on Axsome Therapeutics, Raises Price Target to $165
Benzinga · 8h ago
Axsome Therapeutics Is Maintained at Outperform by Baird
Dow Jones · 9h ago
Baird Maintains Outperform on Axsome Therapeutics, Raises Price Target to $162
Benzinga · 9h ago
Axsome Therapeutics (AXSM) Receives a Buy from Guggenheim
TipRanks · 9h ago
AXSOME THERAPEUTICS INC. <AXSM.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $190 FROM $187
Reuters · 10h ago
More
About AXSM
More
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in developing and delivering therapies for central nervous system (CNS), conditions that have limited treatment options. The Company's two commercial products and development programs are Auvelity and Sunosi. Auvelity (dextromethorphan-bupropion) is an oral, N-methyl-D-aspartate (NMDA) receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder (MDD). Sunosi (solriamfetol) is an oral medication indicated for the treatment of excessive daytime sleepiness (EDS), in patients with narcolepsy or obstructive sleep apnea. AXS-05 is an oral, investigational NMDA receptor antagonist with multimodal activity under development for the treatment of Alzheimer's disease agitation (AD agitation) and smoking cessation. AXS-07 is an oral, rapidly absorbed, multi-mechanistic, investigational medicine under development for the acute treatment of migraine.
Recently
Symbol
Price
%Change

Webull offers Axsome Therapeutics Inc stock information, including NASDAQ: AXSM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXSM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AXSM stock methods without spending real money on the virtual paper trading platform.